Continuous glucose monitoring can benefit patients with type 1 diabetesBMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j364 (Published 25 January 2017) Cite this as: BMJ 2017;356:j364
- Jacqui Wise
Continuous glucose monitoring can improve glycaemic control in patients with type 1 diabetes who use insulin injections, two studies published in JAMA have found.12
This consists of a sensor under the skin with a transmitter attached that reports glucose levels continuously to the patient on a handheld monitor. Most patients whose continuous glucose monitoring has been compared with self monitored blood glucose have used insulin pumps, whereas the two new studies were carried out in patients with type 1 diabetes who injected insulin.
The DIAMOND study included 158 …